230 related articles for article (PubMed ID: 16000217)
21. Comparison of the discriminative-stimulus effects of SKF 38393 with those of other dopamine receptor agonists.
Desai RI; Terry P; Katz JL
Behav Pharmacol; 2003 May; 14(3):223-8. PubMed ID: 12799524
[TBL] [Abstract][Full Text] [Related]
22. Activation of dopamine D1 receptors in the medial prefrontal cortex produces bidirectional effects on cocaine-induced locomotor activity in rats: effects of repeated stress.
Sorg BA; Li N; Wu W; Bailie TM
Neuroscience; 2004; 127(1):187-96. PubMed ID: 15219681
[TBL] [Abstract][Full Text] [Related]
23. Effects of dopamine D1 ligands on eye blinking in monkeys: efficacy, antagonism, and D1/D2 interactions.
Jutkiewicz EM; Bergman J
J Pharmacol Exp Ther; 2004 Dec; 311(3):1008-15. PubMed ID: 15292458
[TBL] [Abstract][Full Text] [Related]
24. Ethological resolution of behavioural topography and D1-like versus D2-like agonist responses in congenic D5 dopamine receptor mutants: identification of D5:D2-like interactions.
O'Sullivan GJ; Kinsella A; Sibley DR; Tighe O; Croke DT; Waddington JL
Synapse; 2005 Mar; 55(4):201-11. PubMed ID: 15668951
[TBL] [Abstract][Full Text] [Related]
25. SKF 38393 reverses cocaine-conditioned place preference in mice.
Sabioni P; D'Almeida V; Andersen ML; Andreatini R; Galduróz JC
Neurosci Lett; 2012 Apr; 513(2):214-8. PubMed ID: 22387069
[TBL] [Abstract][Full Text] [Related]
26. Effects of chronic administration of the D1 receptor partial agonist SKF 77434 on cocaine self-administration in rhesus monkeys.
Mutschler NH; Bergman J
Psychopharmacology (Berl); 2002 Apr; 160(4):362-70. PubMed ID: 11919663
[TBL] [Abstract][Full Text] [Related]
27. Super-stereotypy I: enhancement of a complex movement sequence by systemic dopamine D1 agonists.
Berridge KC; Aldridge JW
Synapse; 2000 Sep; 37(3):194-204. PubMed ID: 10881041
[TBL] [Abstract][Full Text] [Related]
28. Super-stereotypy II: enhancement of a complex movement sequence by intraventricular dopamine D1 agonists.
Berridge KC; Aldridge JW
Synapse; 2000 Sep; 37(3):205-15. PubMed ID: 10881042
[TBL] [Abstract][Full Text] [Related]
29. Effects of dopamine D1-like receptor agonists on food-maintained operant behavior in rats.
Katz JL; Kopajtic TA; Terry P
Behav Pharmacol; 2006 Jun; 17(4):303-9. PubMed ID: 16914948
[TBL] [Abstract][Full Text] [Related]
30. Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists.
Ryman-Rasmussen JP; Nichols DE; Mailman RB
Mol Pharmacol; 2005 Oct; 68(4):1039-48. PubMed ID: 15985612
[TBL] [Abstract][Full Text] [Related]
31. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
Schmidt HD; Pierce RC
Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308
[TBL] [Abstract][Full Text] [Related]
32. Dopamine D1 receptor changes due to caesarean section birth: effects of anesthesia, developmental time course, and functional consequences.
Boksa P; Zhang Y; Bestawros A
Exp Neurol; 2002 Jun; 175(2):388-97. PubMed ID: 12061868
[TBL] [Abstract][Full Text] [Related]
33. D(2), but not D(1) dopamine receptor agonists potentiate cannabinoid-induced sedation in nonhuman primates.
Meschler JP; Clarkson FA; Mathews PJ; Howlett AC; Madras BK
J Pharmacol Exp Ther; 2000 Mar; 292(3):952-9. PubMed ID: 10688609
[TBL] [Abstract][Full Text] [Related]
34. The relationship between reinforcing effects and in vitro effects of D1 agonists in monkeys.
Weed MR; Paul IA; Dwoskin LP; Moore SE; Woolverton WL
J Pharmacol Exp Ther; 1997 Oct; 283(1):29-38. PubMed ID: 9336305
[TBL] [Abstract][Full Text] [Related]
35. A comparison of the effects of cholinergic and dopaminergic agents on scopolamine-induced hyperactivity in mice.
Shannon HE; Peters SC
J Pharmacol Exp Ther; 1990 Nov; 255(2):549-53. PubMed ID: 2243341
[TBL] [Abstract][Full Text] [Related]
36. Role of dopamine in behavioral sensitization to ethanol in DBA/2J mice.
Broadbent J; Kampmueller KM; Koonse SA
Alcohol; 2005 Feb; 35(2):137-48. PubMed ID: 15963427
[TBL] [Abstract][Full Text] [Related]
37. Place conditioning with the dopamine D1-like receptor agonist SKF 82958 but not SKF 81297 or SKF 77434.
Abrahams BS; Rutherford JD; Mallet PE; Beninger RJ
Eur J Pharmacol; 1998 Feb; 343(2-3):111-8. PubMed ID: 9570457
[TBL] [Abstract][Full Text] [Related]
38. The paradoxical effects of SKF83959, a novel dopamine D1-like receptor agonist, in the rat acoustic startle reflex paradigm.
Zhang ZJ; Jiang XL; Zhang SE; Hough CJ; Li H; Chen JG; Zhen XC
Neurosci Lett; 2005 Jul 1-8; 382(1-2):134-8. PubMed ID: 15911136
[TBL] [Abstract][Full Text] [Related]
39. Interactions between dopamine D1 receptors and gamma-aminobutyric acid mechanisms in substantia nigra pars reticulata of the rat: neurochemical and behavioral studies.
Trevitt T; Carlson B; Correa M; Keene A; Morales M; Salamone JD
Psychopharmacology (Berl); 2002 Jan; 159(3):229-37. PubMed ID: 11862355
[TBL] [Abstract][Full Text] [Related]
40. Differential anti-parkinsonian effects of benzazepine D1 dopamine agonists with varying efficacies in the MPTP-treated common marmoset.
Gnanalingham KK; Erol DD; Hunter AJ; Smith LA; Jenner P; Marsden CD
Psychopharmacology (Berl); 1995 Feb; 117(3):275-86. PubMed ID: 7770603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]